A modeling study presented at the 2026 American College of Gastroenterology (ACG) Annual Scientific Meeting suggests that Guardant Health’s Shield blood-based colorectal cancer (CRC) screening test could avert more CRC deaths than stool-based tests when real-world screening adherence and follow-up colonoscopy completion are factored into lifetime projections. Among 1,000 simulated individuals aged 45–75, blood-based screening was projected to result in 679 lifetime colonoscopies and 12 CRC deaths averted, compared with 113 colonoscopies and six deaths averted with fecal immunochemical testing (FIT), and 326 colonoscopies and nine deaths averted with multitarget stool DNA testing. These are modeled projections, not outcomes observed…
Author: Abhay Panchal
Monitored anesthesia care (MAC) has largely replaced endoscopist-directed conscious sedation for routine outpatient GI endoscopy in the United States. However, Megan Adams, MD, JD, MSc, of the University of Michigan, argues that the shift warrants renewed scrutiny because its clinical benefits for low-risk patients remain uncertain, while costs and some complication risks are higher. A 2017 study estimated that MAC use in low-risk patients was associated with approximately $1.5 billion in excess annual spending among Medicare and commercially insured patients. Research has also reported associations between MAC and increased risks of complications, including aspiration and hospitalization, although the absolute difference…
Two machine learning approaches demonstrated 97.5% agreement in identifying colorectal neoplasia across 5,000 colonoscopy reports, according to research presented at the 2026 American College of Gastroenterology (ACG) Annual Scientific Meeting. The retrospective study compared a random forest model with a large language model (LLM) for automated reporting of adenoma detection rate (ADR). Among 123 discordant cases requiring manual review, the random forest model missed two of 16 tubular adenomas, compared with seven missed by the LLM. Both models missed four of 47 sessile serrated lesions. However, the random forest model generated substantially more false positives, incorrectly classifying 92 cases as…
An updated version of Freenome’s SimpleScreen CRC blood test demonstrated improved sensitivity for advanced precancerous lesions (APLs), increasing from 13.7% with the previous version to 18.2%, while maintaining 80.4% sensitivity for colorectal cancer (CRC). The late-breaking findings were presented at the 2026 American College of Gastroenterology (ACG) Annual Scientific Meeting. The updated test incorporates assay modifications to improve signal detection and refinements to its algorithm for identifying circulating tumor DNA. Validation drew on the PREEMPT CRC study, which enrolled 48,995 average-risk adults aged 45–85 undergoing screening colonoscopy. In the evaluable cohort, specificity was 90.0% among participants with no colonoscopic findings.…
U.K.-based Microbiotica has raised £36 million (€43 million) in the first close of its Series C financing round, led by the British Business Bank, to advance MB310, its investigational microbiome therapy for ulcerative colitis (UC), into Phase 2. Other investors include Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest and Seventure Partners, alongside existing Series B investors. MB310 is a once-daily capsule containing eight live bacterial strains selected from research into fecal microbiota transplantation. The therapy is designed to establish beneficial bacteria in the gut and potentially support remission without directly suppressing the immune system. In the Phase 1b COMPOSER-1…
A study of 41,606 patients at Kaiser Permanente Northern California found that nearly one-third of patients with one or two nonadvanced adenomas continued to receive surveillance colonoscopy recommendations earlier than guidelines advise. The findings, published in Clinical Gastroenterology and Hepatology, highlight persistent gaps in implementing updated colorectal cancer (CRC) surveillance guidance. In 2020, the U.S. Multi-Society Task Force extended the recommended surveillance interval for patients with one or two nonadvanced adenomas from five to 10 years to seven to 10 years. Adherence improved from 68% in 2021 to 72% in 2024, but 28%–32% of patients were still advised to return…
Gastro Health has announced a strategic partnership with Echosens to integrate FibroScan technology across its U.S. network, expanding access to non-invasive liver assessment for patients at risk of metabolic liver disease. FibroScan enables physicians to assess liver health without a biopsy in many cases, helping identify patients who may need further evaluation and monitor disease progression over time. The partnership aims to incorporate liver assessment into routine gastroenterology visits, reducing fragmented care and supporting earlier identification of liver disease in patients with obesity, diabetes and other metabolic risk factors. According to Gastro Health Medical Director of Clinical Quality Dr. Jose…
ModMed has announced an expanded gGastro Suite that brings AI into clinical documentation, ASC workflows, revenue cycle management and practice operations for gastroenterology practices. The company says the investment is intended to reduce administrative burden and connect workflows that are often managed through separate systems. The expanded suite adds ModMed Scribe, an ambient AI documentation tool that captures patient-provider conversations, suggests structured notes and diagnosis codes, and can support downstream workflows such as prescriptions, lab orders and patient education. General availability is expected in early 2027. ModMed is also introducing an agentic RCM AI platform designed to reduce denials, automate…
CRH Anesthesia, a subsidiary of CRH Medical Corporation, has acquired a majority interest in Southern Colorado Anesthesia Associates (SCAA), establishing a strategic partnership with Associates in Gastroenterology in the Colorado Springs market. The transaction adds 10 gastroenterologists to CRH’s physician-partner network and expands its Colorado presence to 17 locations. Associates in Gastroenterology and SCAA collectively serve patients at two ambulatory surgery centers (ASCs) in the region. According to the companies, the partnership will simplify anesthesia-service management and support the continued development of the practice’s surgical center operations. For CRH, the deal represents further expansion of its GI-focused anesthesia platform and…
A study published in Gastro Hep Advances evaluated ColoPrep, a two-way text messaging program designed to help patients prepare for and attend scheduled colonoscopies. The study included 36,160 patients across three outpatient endoscopy facilities at an academic health system in the Philadelphia region. The program sends appointment reminders, answers common bowel preparation questions and connects patients with staff when additional guidance is needed. Following implementation, colonoscopy completion rates increased by 5.9 percentage points more at intervention sites than at the control site. When sigmoidoscopies were excluded, the difference was 8.4 percentage points. Among Black patients, the results showed a similar…
